- Title
- 225 - High Efficacy and Low Toxicity of MB-106, a Third Generation CD20 Targeted CAR-T for Treatment of Relapsed/Refractory B-NHL and CLL
- Creators
- Mazyar ShadmanCecilia CS YeungMary RedmanSang Yun LeeDong Hoon LeeSusan RaChaitra S UjjaniBruce J DezubeChristina PohEdus H. WarrenAude G. ChapuisDamian J. GreenAndrew J. CowanRyan D. CassadayHans-Peter KiemJordan GauthierCameron J. TurtleRyan C. LynchStephen D. SmithAjay K. GopalDavid G. MaloneyBrian G. Till
- Publication Details
- Transplantation and cellular therapy, Vol.28(3), pp.S182-S183
- Publisher
- Elsevier Inc
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- Record Identifier
- 991032007860502976
Journal article
225 - High Efficacy and Low Toxicity of MB-106, a Third Generation CD20 Targeted CAR-T for Treatment of Relapsed/Refractory B-NHL and CLL
Transplantation and cellular therapy, Vol.28(3), pp.S182-S183
2022-03
Metrics
1 Record Views